Cell Therapy Community Resources

  

Glossary of Cell Therapy Terms

Regulatory, Quality and Operations
Circular of Information: Use of Cellular Therapy Products (2016)
International Society for Cellular Therapy Facility Sanitization Survey Laboratory Practices Committee Report  (Cytotherapy 2015, 17: 850-859,  ISCT Lab Practices Committee)
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholder's concerns (Cytotherapy 2014, 16: 1597-1600, ISCT Europe Legal and Regulatory Affairs Committee)
BEACON: Regulatory, Quality and Operations Database
Cell Therapy Liaison Meetings 

 

Commercialization
Managing particulates in cell therapy: Guidance for best practice (Cytotherapy 2016, In Press Corrected Proof, ISCT Process and Product Development Subcommittee)
Off the shelf cellular therapeutics: Factors to consider during cryopreservation and storage of human cells for clinical use (Cytotherapy 2016, 18:697-711, ISCT Process and Product Development Subcommittee)
Critical elements in the development of cell therapy potency assays for ischemic conditions (Cytotherapy 2015, 17:817-831, ISCT Process and Product Development Subcommittee)
Concise Review: Guidelines in Developing Commercializable Autologous/Patient-Specific Cell Therapy Manufacturing (Stem Cells Trans Med 2013, 2:871-883, ISCT Product and Process Development Subcommittee) 
Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry (Cytotherapy 2013, 15:9-19, ISCT Process and Product Development Subcommittee)
Managing particulates in cellular therapy (Cytotherapy 2012, 14:1032-1040, ISCT Process and Product Development Subcommittee)
Hematopoietic Stem Cell Transplantation and Implications for Cell Therapy Reimbursement (Cell Stem Cell 2011, 8:609-612, ISCT Reimbursement Subcommittee)
Cell Therapy Bioprocessing - Integrating Process and Product Development for the Next Generation of Biotherapeutics (BioProcess International 2011 Supplement, ISCT Product and Process Development Subcommittee)
BEACON: Tools and Reagents Database
ISCT Cost of Goods Survey Results  (2013, ISCT Business Models and Cost of Goods Subcommittee)

 

Scientific
Tracheal bioengineering: the next steps. Proceeds of an International Society for Cellular Therapy Pulmonary Cellular Therapy Signature Series Workshop, Paris, France, April 22, 2014 (Cytotherapy 2014, 16:1601-1613, ISCT Pulmonary Committee)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement (Cytotherapy 2006, 8(4): 315-317, ISCT Mesenchymal Stem Cell Committee)

 

Medical Tourism and Unproven Cellular Therapies
ISCT Presidential Task Force on the Use of Unproven Cellular Therapies: Reference Guide (Cytotherapy 2016)
Patient Advisory for Stem Cell Therapy and Medical Tourism (August 2013)
Cell therapy medical tourism: Time for action (Cytotherapy 2010, 12:965-968)

 

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.